Polymyalgia rheumatica
DOI:
https://doi.org/10.5324/nje.v18i1.63Sammendrag
Polymyalgia rheumatica (PMR) er en sykdom som rammer personer over 50 år og som forekommer hyppigst i de Skandinaviske land. Insidensen i Norge er beregnet til omkring 112 per 100.000 personer over 50 år. Mortaliteten er ikke signifikant økt, og det er ingen sikker økt risiko for utvikling av kreftsykdom. Ikke sjelden blir diagnostikk og behandling ivaretatt av allmennpraktiserende leger slik at kunnskap fremkommet ved analyser av sykehusinnlagte pasienter ikke umiddelbart vil gjelde hele pasientpopulasjonen. Vår kunnskap om sykdommen er fortsatt fragmentert og mangelfull. I Norge burde det være gode forutsetninger for å kunne gjennomføre god epidemiologisk og klinisk forskning basert på et samarbeid mellom første- og annenlinjetjenesten.
Polymyalgia rheumatica (PMR) is a common disease in the elderly. The highest incidence is found in Scandinavia. There is no increased risk of concomitant malignant disease, and mortality equals that of the general population aged 50 years or more. In most cases, diagnosis and therapy are made by general practitioners. The knowlegde about this condition is still incomplete. In Norway, scientific research should be organised through collaboration between referral centers and general practitioners
Downloads
Nedlastinger
Publisert
Hvordan referere
Utgave
Seksjon
Lisens
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
